For women of reproductive age with suspected or diagnosed adenomyosis, the recommended first-line treatment option for managing heavy menstrual bleeding (HMB) symptoms is the **levonorgestrel-releasing intrauterine system (LNG-IUS)** NICE NG88. It is important to note that this is an off-label use for some LNG-IUSs NICE NG88. If a woman declines an LNG-IUS or it is not suitable, other pharmacological treatments can be considered NICE NG88. These include non-hormonal options such as **tranexamic acid** and **non-steroidal anti-inflammatory drugs (NSAIDs)** NICE NG88. Hormonal alternatives include **combined hormonal contraception** and **cyclical oral progestogens** NICE NG88. NSAIDs and some combined hormonal contraceptives are also used off-label for this indication NICE NG88.
What are the recommended first-line treatment options for managing
Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP.
Posted: 16 August 2025Updated: 16 August 2025 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MSt MRCGPClinical Lead • iatroX
Related Questions
- treatment of vaginal thrush in women
- Panic disorder management in primary care: initial treatment steps?
- Mx of constipation in adults: lifestyle changes + first-line pharmacological tre
- Recommended approach to diagnosing heart failure in primary care, including role
- Initial mx of atopic eczema in kids: skincare and topical treatments
Continue exploring
Related clinical resources
Explore these topics in the iatroX reference and learning libraries.